What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in Q2 2015?

137 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

CUSIP: 03152W109

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 312,579,912
Total 13F shares: 112,532,503
Share change: +30,913,371
Total reported value: $1,592,136,319
Put/Call ratio: 80%
Price per share: $14.15
Number of holders: 137
Value change: +$450,570,258
Number of buys: 94
Number of sells: 59

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	4.6%	14,439,444	$157,101,000	—	31 Mar 2015	13F
Redmile Group, LLC	13F	Company	1.9%	5,832,228	$63,455,000	—	31 Mar 2015	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.6%	4,986,138	$54,249,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	4,316,935	$46,968,000	—	31 Mar 2015	13F
Avoro Capital Advisors LLC	13F	Company	1.3%	4,211,399	$45,820,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	1.3%	3,920,077	$42,650,000	—	31 Mar 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.82%	2,569,326	$27,954,000	—	31 Mar 2015	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	0.82%	2,564,545	$27,902,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	0.82%	2,550,728	$27,752,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	0.78%	2,431,229	$26,452,000	—	31 Mar 2015	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.63%	1,964,565	$21,374,000	—	31 Mar 2015	13F
Palo Alto Investors LP	13F	Company	0.63%	1,956,376	$21,285,000	—	31 Mar 2015	13F
FRANKLIN RESOURCES INC	13F	Company	0.63%	1,954,400	$21,264,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.48%	1,501,433	$16,336,000	—	31 Mar 2015	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.46%	1,436,694	$15,631,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	0.43%	1,359,173	$14,788,000	—	31 Mar 2015	13F
S.c.a. Candriam	13F	Individual	0.43%	1,350,000	$14,691,000	—	31 Mar 2015	13F
MARSHALL WACE, LLP	13F	Company	0.38%	1,195,514	$13,007,000	—	31 Mar 2015	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.37%	1,146,506	$12,473,985	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.37%	1,141,356	$12,418,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.33%	1,039,535	$11,310,000	—	31 Mar 2015	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.32%	1,010,000	$10,989,000	—	31 Mar 2015	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.27%	836,609	$9,102,000	—	31 Mar 2015	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.23%	727,200	$7,912,000	—	31 Mar 2015	13F
LORD, ABBETT & CO. LLC	13F	Company	0.22%	689,719	$7,504,000	—	31 Mar 2015	13F
EMERALD ADVISERS, LLC	13F	Company	0.22%	702,309	$7,487,000	—	31 Mar 2015	13F
Independence Capital Asset Partners, LLC	13F	Company	0.21%	665,671	$7,243,000	—	31 Mar 2015	13F
Informed Momentum Co LLC	13F	Company	0.2%	625,694	$6,808,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.2%	621,249	$6,759,000	—	31 Mar 2015	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.19%	581,562	$6,199,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	0.18%	562,204	$6,117,000	—	31 Mar 2015	13F
Forward Management, LLC	13F	Company	0.2%	636,880	$6,046,000	—	31 Mar 2015	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.19%	594,209	$5,978,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	466,252	$5,073,000	—	31 Mar 2015	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.15%	458,701	$4,991,000	—	31 Mar 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.14%	450,000	$4,896,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.14%	445,147	$4,841,000	—	31 Mar 2015	13F
Numeric Investors LLC	13F	Company	0.14%	434,900	$4,732,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	407,731	$4,436,000	—	31 Mar 2015	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.13%	402,068	$4,374,000	—	31 Mar 2015	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.12%	363,197	$3,952,000	—	31 Mar 2015	13F
Ghost Tree Capital, LLC	13F	Company	0.11%	350,000	$3,808,000	—	31 Mar 2015	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	289,334	$3,148,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.09%	265,718	$2,891,000	—	31 Mar 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.08%	260,945	$2,839,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.08%	253,449	$2,758,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.08%	244,962	$2,665,000	—	31 Mar 2015	13F
APIS CAPITAL ADVISORS, LLC	13F	Company	0.08%	262,000	$2,633,000	—	31 Mar 2015	13F
ClariVest Asset Management LLC	13F	Company	0.07%	222,810	$2,424,000	—	31 Mar 2015	13F
ADAMS STREET PARTNERS LLC	13F	Company	0.07%	206,763	$2,250,000	—	31 Mar 2015	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2015

As of 30 Jun 2015, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,532,503 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, Sectoral Asset Management Inc, venBio Select Advisor LLC, Citadel Advisors LLC, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC. This page lists 137 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

122

Q2 2015 holders

137

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.